Michael Ryskin
BofA Securities, Research Division

We'll kick things off. Thanks, everyone, for joining us. My name is Mike Ryskin. I'm on the Bank of America Life Science Tools and Diagnostics team, and I'm excited to host for our next session, Schrödinger. We're joined by Ramy Farid, Chief Executive Officer; Richie Jain, Chief Financial Officer; and Pat Lorton, EVP, CTO and COO of Software. Ramy, Richie, Pat, thank you so much for being here. Thanks for taking the time.

Ramy Farid
CEO, President & Director

Thanks so much for having us. Looking forward to the discussion.

Michael Ryskin
BofA Securities, Research Division

So the format will be a fireside chat with some Q&A. If you've got a burning question, raise your hand, and we'll incorporate you in. But maybe just to kick things off, Ramy, maybe one for you. Just you recently reported 1Q earnings, reiterated your full year guide. What are the key takeaways from the quarter, how it played out relative to your expectations? There's been a lot of moving pieces in the model the last couple of months. So let's talk through it a little bit.

Ramy Farid
CEO, President & Director

Yes. I mean, of course, the performance itself was -- we were very pleased. We actually slightly exceeded the guidance that we gave. But I think beyond that, I mean, obviously, that's good. But beyond that, I think how broad the source of growth was. We saw existing customers, large customers scaling up their usage. We saw companies adding new products. That's always an exciting thing. When you